Pancreatic Cancer Research

ResearcherErasmus MCActive in the last 2 years

Inge M.C.M. de Kok

ORCID-verified (high confidence, 0.95), identity_conf@1As of 7 November 2026

Matched on ORCID iD 0000-0002-9419-0452; OpenAlex author ID A5081524520. Sources: OpenAlex.

Their work

Papers
3 (first author 0, last author 3)
Trials
0
Grants
0
Labs led
1
Collaborators
7
Papers, trials and grants by year

2021: 1 paper · 2022: none · 2023: 1 paper · 2024: none · 2025: none · 2026: 1 paper

Papers 3

  1. Healthcare expenditures across the care continuum of pancreatic cancer and resected precursor lesions. Last author DOI 10.1016/j.pan.2026.10.005↗
  2. The impact of pancreatic cancer screening on life expectancy: A systematic review of modeling studies. Last author DOI 10.1002/ijc.34379↗
  3. Identifying key factors for the effectiveness of pancreatic cancer screening: A model-based analysis. Last author DOI 10.1002/ijc.33540↗

Closest collaborators

The 7 strongest of 7 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

  1. Marco J. Bruno · 3 shared papers, 2021–2026 · strength 0.62
  2. Djuna L. Cahen · 3 shared papers, 2021–2026 · strength 0.62
  3. Brechtje D.M. Koopmann · 2 shared papers, 2021–2023 · strength 0.34
  4. Marloes L. J. A. Sprij · 1 shared paper, 2026 · strength 0.28
  5. Ingrid C. A. W. Konings · 1 shared paper, 2021 · strength 0.12
  6. Jeanin Elise van Hooft · 1 shared paper, 2021 · strength 0.12
  7. Femme Harinck · 1 shared paper, 2021 · strength 0.12

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.